TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
RPH Pharmaceuticals AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
29,686
|
20,740
|
17,582 |
Financial expenses |
2,891
|
1,609
|
2,080 |
Earnings before taxes |
4,004
|
3,342
|
4,900 |
EBITDA |
9,851
|
6,697
|
5,251 |
Total assets |
28,851
|
27,019
|
37,902 |
Current assets |
9,759
|
8,512
|
21,449 |
Current liabilities |
25,121
|
22,940
|
32,334 |
Equity capital |
3,467
|
3,816
|
5,006 |
- share capital |
9
![]() |
9
|
10 |
Employees (average) |
0
![]() |
0
![]() |
0 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
12.0%
|
14.1%
|
13.2% |
Turnover per employee | |||
Profit as a percentage of turnover |
13.5%
|
16.1%
|
27.9% |
Return on assets (ROA) |
23.9%
|
18.3%
|
18.4% |
Current ratio |
38.8%
|
37.1%
|
66.3% |
Return on equity (ROE) |
115.5%
|
87.6%
|
97.9% |
Change turnover |
8,886
|
4,582
|
3,844 |
Change turnover % |
43%
|
28%
![]() |
28% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.